EQT

Avidicure is a cancer care company focused on enhancing immune system function through innovative therapies. It is developing a novel antibody modality known as "AVC-Boosters," which are dual agonistic and multifunctional, engineered to deliver targeted and effective monotherapy. This approach aims to provide broad applicability in oncology, addressing various cancer types while prioritizing safety and efficacy. Currently, Avidicure is operating in stealth mode, indicating a focus on research and development before public engagement.

EAGLE RAILCAR SERVICES is one of the nation's leading independent providers of railcar repair services.

ReliaQuest is a cybersecurity company founded in 2007 and headquartered in Tampa, Florida. It offers a cloud-native security platform called GreyMatter, which provides comprehensive visibility across Security Information and Event Management (SIEM), Endpoint Detection and Response (EDR), and multi-cloud environments. This platform is designed to automate and streamline the security lifecycle, enabling organizations to enhance their security posture while minimizing data loss and business disruptions. By facilitating real-time data analysis and contextual interpretation, ReliaQuest helps clients make informed security decisions and maintain compliance, ultimately fostering security confidence and resilience against potential breaches.

Perfuze is a neurovascular medical device company based in Galway, Ireland, established in 2018. The company specializes in developing innovative catheter technology aimed at treating acute ischemic stroke. By utilizing its proprietary catheter-based aspiration platform, Perfuze focuses on optimizing the efficiency of clot removal, which in turn seeks to enhance clinical outcomes and reduce procedural times. This technology aims to simplify the treatment process while minimizing the need for alternative interventions, providing patients with a cost-effective solution for ischemic stroke therapy.

TravelPerk is a comprehensive platform that streamlines business travel management by integrating booking, reporting, and support into a single tool. It enables users to easily book flights, hotels, and car rentals while ensuring adherence to company policies. The platform offers a wide range of travel options and features, including automated policies, expense integrations, and customer service support. With its user-friendly interface and advanced technology, TravelPerk helps organizations manage their travel needs efficiently, control costs, and simplify the overall booking process for employees. By combining various travel services into one solution, it aims to enhance the travel experience for businesses and reduce the complexities associated with managing business trips.

Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.

Scale Microgrid Solutions designs, builds, operates, and finances on-site power systems for commercial and industrial facilities across North America. Founded in 2016 and based in Ridgewood, New Jersey, the company specializes in creating multi-resource clean energy microgrids that support renewable energy generation for daily operations and during power outages. Their offerings include the rapid response modular microgrid (R2M2), which optimizes solar power, battery storage, and dispatchable generation. By providing fully-financed microgrids and distributed energy services, Scale Microgrid Solutions aims to deliver sustainable and reliable power while alleviating the complexities traditionally associated with microgrid development. Their approach ensures clients benefit from innovative energy technologies, contributing to a cleaner and more resilient energy infrastructure.

XyloCor Therapeutics, based in Newtown Square, Pennsylvania, is a biopharmaceutical company dedicated to developing gene therapies for the treatment of cardiovascular diseases, particularly advanced coronary artery disease. Its lead product candidate, XC001, is currently in clinical development for patients suffering from refractory angina, addressing critical unmet medical needs for those who have exhausted conventional treatment options. Additionally, the company is developing XC002, aimed at regenerating cardiac tissue in patients with compromised heart function due to previous heart attacks and resultant heart failure. XyloCor's innovative gene therapy technologies focus on stimulating the formation of new coronary blood vessels, thereby improving blood supply to areas of the heart that are insufficiently perfused. The company collaborates with Weill Cornell Medical College to enhance its therapeutic approaches and outcomes for patients.

Tenpoint Therapeutics is a biotechnology company dedicated to developing engineered cell-based therapies aimed at restoring vision for individuals with degenerative ocular diseases. The company's innovative platform focuses on creating treatments that can be delivered directly to the eye, eliminating the need for systemic administration. This targeted approach enhances the potential for effective intervention, allowing healthcare providers to significantly improve the quality of life for patients suffering from various eye conditions. Through its commitment to advancing vision-restoring technologies, Tenpoint Therapeutics is positioned to make a meaningful impact in the field of ocular health.

Noema Pharma AG is a biotechnology company based in Basel, Switzerland, founded in 2019. The company focuses on developing therapeutic products and therapies for orphan neurological disorders characterized by imbalanced neuronal networks. Its research and development efforts aim to address disabling symptoms in conditions affecting the nervous system, including Tuberous Sclerosis Complex, Trigeminal Neuralgia, and Tourette syndrome. By creating novel therapies, Noema Pharma seeks to improve the quality of life and patient outcomes for individuals suffering from these rare conditions.

NUA Surgical is an innovative start-up located at the Innovation Hub in Galway, Ireland, focused on enhancing women's health through advanced medical devices. The company has developed a patented surgical retractor specifically designed to improve the safety and efficiency of cesarean deliveries. By concentrating on research and development, NUA Surgical aims to provide obstetricians with tools that facilitate superior surgical outcomes, ultimately making C-sections safer for patients.

JUNIZ focuses on sustainable real estate and renewable energy solutions, including large-scale energy storage systems.

Calisen plc is a company based in Manchester, United Kingdom, that owns and manages essential energy infrastructure assets. It operates through two main business units: Calvin Capital and Lowri Beck. Calvin Capital focuses on procuring and managing a portfolio of electricity and gas meters, primarily smart meters, on behalf of energy retailers. Meanwhile, Lowri Beck provides installation, meter reading, and maintenance services for these retailers, along with ancillary services such as customer support. Calisen is actively involved in the ongoing government-mandated rollout of smart meters in Britain and aims to support the transition to cleaner and more sustainable energy solutions. The company was incorporated in 2020.

ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.

PageUp People Limited is a provider of a cloud-based talent management platform that assists organizations in managing various aspects of human resources, including recruitment, onboarding, learning, performance, and succession planning. The company offers a comprehensive suite of services that includes recruitment and selection, performance management, training and development, retention strategies, and career tracking. Its clientele comprises notable organizations such as AEGIS, AngloAmerican, and National Australia Bank. Founded in 1980 and headquartered in Melbourne, Australia, PageUp also has offices in Sydney, Singapore, Hong Kong, New York, and London, allowing it to serve multinational clients effectively. The platform is designed to integrate multiple HR functions, providing analytics and insights that support both strategic and operational decision-making in talent management.

Neara provides a cloud-based platform designed for the electric and power infrastructure industry, focusing on predictive modeling software. This platform allows utilities to proactively manage their networks by simulating severe weather scenarios and identifying vulnerabilities within their systems. By employing predictive algorithms, Neara offers a three-dimensional, physics-enabled model that enhances visualization and reporting for energy businesses. This capability aids in optimizing asset management across the entire network, ensuring informed decision-making and improved governance of utility operations.

Vinted operates an online marketplace intended to make second-hand the first choice. Its platform offers a peer-to-peer marketplace for girls and women to buy, sell, and swap clothes with an online chatting feature, enabling users to shop with ease at low cost.

Sequana Medical AG is a Swiss medical device company that specializes in developing implantable pump systems to manage fluid balance in the body. Its flagship product, the alfapump, is designed to continuously remove ascites, a condition characterized by fluid accumulation in the abdominal cavity, commonly seen in patients with advanced liver disease, certain cancers, or congestive heart failure. The alfapump is notable for being the first automated system that facilitates the natural expulsion of excess fluid through urination. In addition to treating ascites, the company's pump technology has potential applications in managing pleural effusions and fluid overload in patients with end-stage renal disease and heart failure. Founded in 2002 and headquartered in Zurich, Switzerland, Sequana Medical has expanded its reach to various markets, with a significant portion of its revenue generated in Germany.

Indostar Home Finance is a housing finance company that provides mortgages to retail clients in tier 2 to tier 4 cities and has supported low-income homeowners and small companies.

PanTera focuses on the large-scale production of actinium-225, a promising radioisotope for targeted cancer therapies. The company aims to improve accessibility to personalized nuclear medicine treatments while ensuring sustainability through the recycling of materials in their production process.

GeBBS Healthcare Solutions, Inc. is a technology-enabled provider of revenue cycle and health information management solutions, established in 2005 and headquartered in Culver City, California. The company offers a range of services, including risk adjustment, patient access, and revenue integrity solutions, aimed at enhancing financial performance, compliance, and patient satisfaction. With a workforce of over 6,000 employees, GeBBS serves a variety of clients, including hospitals, physician groups, health plans, and medical billing companies. The organization has formed strategic partnerships with industry groups to strengthen its offerings. GeBBS has received multiple accolades for its services, being recognized as one of the largest revenue cycle management firms and one of the fastest-growing private companies in the United States.

Compass Education is a cloud-based school management platform designed to enhance parent engagement while reducing administrative burdens for educational institutions. Operating in regions including Victoria, New South Wales, Brisbane, and Dublin, the platform offers a versatile student information system that supports multiple languages and currencies. It features a wide array of modules, including attendance tracking, reporting, parent communication, student well-being, and learning management. Additionally, Compass Education facilitates staff development, online payments, event management, and data analytics, enabling schools to streamline their processes. By allowing administrators to efficiently manage school data and generate reports, the platform helps them focus on fostering strong connections within the school community.

PropertyGuru Limited is a property technology company that operates online property classifieds marketplaces across Singapore, Vietnam, Malaysia, Thailand, and Indonesia. Established in 2006 and headquartered in Singapore, the company connects property agents and developers with consumers seeking residential and commercial properties for sale or rent. Its flagship website, PropertyGuru.com.sg, serves as Singapore's leading property portal, attracting over 4.5 million users who access more than 50 million pages. PropertyGuru offers a range of services, including digital marketing for property agents, software solutions for sales process automation aimed at developers, and a digital mortgage marketplace. Additionally, the company provides consultancy services for banks, valuers, and property developers, further enhancing its role in the real estate ecosystem.

KJ Environment is an environmental and energy infrastructure specialist is establishing a scaled and diverse end-to-end waste treatment platform focusing on plastic recycling and waste-to-electricity conversion.

AMCS Group are an Irish company that are involved in the provision of RFID (Radio Frequency Identification) solutions. James Martin and Austin Ryan established advanced Manufacturing Control Systems (AMCS) Ltd in 2002. It is an Irish company with headquarters in the Innovation Works in Castletroy, Limerick. AMCS has an experienced team of engineers and technicians who combine technically advanced solutions with first class customer support, AMCS Group is the world's provider of integrated, end-to-end software and solutions for the waste, recycling, logistics and resource management industry.From cutting edge Weighing & RFID technology to a full suite of ERP software with ELEMOS, AMCS solutions can cover all aspects of your operation from bin, vehicle & skip management, mobile computing & weighbridge control to invoicing, customer reporting & analysis.The company’s solutions are used by the worlds leading municipalities, private recycling and waste collectors and commercial waste haulers providing residential, commercial, hazardous,recycling and disposal services.

Acronis, Inc. specializes in data protection and cybersecurity solutions, offering a comprehensive range of services that include backup software, disaster recovery, and secure data access for consumers and businesses of all sizes. Founded in 2000 and headquartered in Woburn, Massachusetts, Acronis provides tools for physical, virtual, and cloud environments, ensuring the protection of data across various devices and operating systems. The company's offerings include the Acronis AnyData engine, which safeguards data across diverse storage locations, and Acronis Files Connect, facilitating file access for Mac users. Acronis also delivers integrated cyber protection through its innovative Cyber Protect solution, combining antivirus, backup, and endpoint protection management powered by artificial intelligence. With a global presence in over 150 countries and a customer base that includes service providers and sectors such as public, healthcare, and publishing, Acronis has established itself as a leader in the field, supporting over 750,000 businesses worldwide.

Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases. Tauopathies are currently untreatable neurodegenerative diseases that rapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.

Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

WSO2 Inc. specializes in open-source enterprise middleware solutions, catering to a diverse range of sectors, including healthcare, finance, and technology. Founded in 2005 and headquartered in Mountain View, California, WSO2 provides a comprehensive platform that allows enterprise architects to build, integrate, manage, secure, and analyze APIs, applications, and microservices across various environments, including on-premises and cloud. Its offerings include WSO2 Developer Studio for application development, WSO2 Private PaaS for hosting middleware products, and cloud solutions such as WSO2 App Cloud and WSO2 API Cloud, which facilitate application development and enable enterprises to share capabilities globally. WSO2 also addresses customer identity and access management needs through WSO2 Identity Cloud, incorporating user feedback to enhance its services. The company supports thousands of enterprises, executing over 60 trillion transactions and managing more than 1 billion identities annually, with a workforce of over 800 employees across multiple international locations.

Universidad Europea is an innovative institution geared towards adding value to society and contributing to its progress.

Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, focused on developing point-of-care diagnostic solutions for infectious diseases. Established in 2005, the company offers the binx io system, a FDA-cleared and CLIA-waived platform that detects sexually transmitted infections, including chlamydia and gonorrhea, delivering results comparable to central lab performance within approximately thirty minutes. Additionally, Binx Health provides the Callisto system, which meets various throughput requirements for testing in decentralized and near-patient settings. The company's innovative approach aims to enhance access to healthcare by overcoming traditional barriers and improving patient experiences through rapid polymerase chain reaction (PCR)-based testing and a comprehensive digital program that includes counseling and follow-up care. Binx Health has also formed a strategic partnership with Sherlock Biosciences to further advance its capabilities in diagnostics.

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Tubulis GmbH, founded in 2019 and based in Munich, Germany, specializes in the research, design, and development of protein-drug conjugates, particularly transformative antibody-drug conjugates (ADCs). The company focuses on creating innovative chemotherapeutic medications that are specifically tailored to combat cancer and chronic disorders. By integrating proprietary technologies with disease-specific biology, Tubulis aims to identify novel protein-drug combinations that enable clinicians to treat cancer patients while minimizing the risks and side effects typically associated with traditional chemotherapy.

Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. The approach is to harness the brain's own capacity for relearning functions that have been lost through brain damage (via "neuroplasticity" or "cortical remapping"). Focusing initially on the care of stroke patients as they recover in hospital (acute care), Prof Shaheen Hamdy of the University of Manchester, UK, painstakingly devised a method of delivering electrical signals from the pharynx (throat) along nerve cells directly to the relevant parts of the brain. The results of his work have been published in top peer-reviewed scientific and medical journals, including The Lancet, the Nature group of publications, and Gastroenterology.

Onera Health, Inc. specializes in providing innovative sleep diagnostic solutions and services aimed at identifying sleep disorders such as insomnia, sleep apnea, and narcolepsy. Founded in 2017 and headquartered in Palo Alto, California, with a research and development office in Eindhoven, the Netherlands, Onera Health has developed advanced sleep diagnostic patch systems that collect and analyze sleep data. These systems not only enhance the diagnosis of sleep-related ailments but also have potential applications in monitoring various chronic health conditions. By delivering comprehensive sleep test data to healthcare providers, Onera Health aims to improve patient care and reduce healthcare costs, ultimately enhancing the health and quality of life for individuals globally.

InstaVolt is leading the way in EV charging infrastructure, helping to make the UK an easier place to own and operate an electric vehicle. They own, install and maintain rapid electric vehicle charging units all over the country, giving landowners the opportunity to earn a rental income by housing them, and giving EV drivers access to the fastest charging available. They are driven by their passion for protecting the environment. At their core is a mission to improve air quality and reduce carbon emissions. Air quality has reached critical levels in cities across the UK and cars, buses and lorries have been proven as contributing significantly to the problem. Increasing the use of electric vehicles, which emit zero emissions, is an important part of the solution. According to Government statistics, one of the biggest barriers that deters people from buying EVs is range anxiety – the fear of running out of charge. InstaVolt will ensure a rapid charging point is easily accessible to everyone in the country. They believe that charging an electric vehicle should be quick and easy. It’s why, unlike many other companies, they operate an ‘open charger’ model, so anyone can use their charging points on a pay-as-you-go basis. No monthly subscription and no membership cards are required.

Vico Therapeutics B.V., founded in 2019 and based in Leiden, the Netherlands, specializes in developing RNA modulating therapies aimed at treating rare neurological disorders. The company's primary focus is on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome. By discovering and delivering innovative therapies, Vico Therapeutics aims to address the unmet medical needs of patients suffering from these severe central nervous system disorders, thereby enhancing treatment options available to medical professionals.

HVD Group offers cloud-based end-to-end field service management and enterprise resource planning software with key functionalities such as order, project and asset management, scheduling, time reporting, procurement and documentation handling.

LUMA Vision is a company focused on developing connected intra-vascular medical devices to enhance the treatment of cardiac arrhythmias. By leveraging advanced four-dimensional imaging and artificial intelligence, LUMA Vision aims to transform electrophysiology and structural heart interventions. Their technology facilitates real-time tissue analysis, enabling healthcare professionals to perform cardiac procedures more effectively. This innovation is designed to improve patient outcomes, enhance procedural safety, and ultimately lower costs within the healthcare system.

Shinobi Therapeutics specializes in the development of cell therapies that leverage hypoimmune CD8αβ iPS-T cells to interact with the immune system for the treatment of cancer and various genetic diseases. The company's innovative approach incorporates advanced immune evasion technology to enhance the effectiveness and accessibility of these therapies. By focusing on durable responses and the potential for redosing, Shinobi aims to reduce costs and improve patient outcomes in the healthcare sector.

HRBrain, Inc. operates an online platform that delivers cloud-based human resource evaluation services. Founded in 2016 and headquartered in Tokyo, Japan, the company offers centralized management of human resource data, facilitating personal evaluations, organizational structure, and performance analysis. Its platform streamlines the management and assessment of employee goals, allowing businesses to set targets and evaluate performance efficiently. By visualizing and analyzing accumulated evaluation data, HRBrain enables companies and HR personnel to develop effective management strategies and measures, enhancing overall workforce management.

Nouscom is a biotechnology company focused on developing an immunotherapy platform that creates modified viral vector vaccines for cancer treatment. The company utilizes a range of engineered viral vectors optimized for the effective expression of long strings of tumor neoantigens. Additionally, its platform includes tools designed to induce broad and potent antitumor T-cell responses, which aim to enhance cancer-specific cellular immunity in patients.

Statera Energy is a company that generates, transmissions, and distributes electric energy.

AgomAb Therapeutics N.V., based in Gent, Belgium, focuses on developing innovative therapies using anti-MET antibodies for treating various diseases. The company specializes in creating agonistic monoclonal antibodies, known as agomAbs, which aim to stimulate molecular and cellular repair mechanisms to regenerate damaged tissues. This approach has the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative conditions. AgomAb is committed to exploring biologically validated pathways, particularly Transforming Growth Factor β and Hepatocyte Growth Factor, and is equipped with expertise in organ-specific small molecules and high-affinity antibodies. With a diversified clinical pipeline targeting multiple fibrotic conditions and comprehensive research and development capabilities, AgomAb Therapeutics is well-positioned in the therapeutic landscape.

Minervax is focused on developing a vaccine to prevent infections caused by Group B streptococcus (GBS), which can lead to serious health issues in newborns and adverse pregnancy outcomes. The company is researching a specific fusion protein that has demonstrated the ability to stimulate strong protective immunity against various clinically significant GBS strains. By utilizing this innovative approach, Minervax aims to provide medical professionals with an effective tool to protect newborns from potentially life-threatening bacterial infections associated with GBS.

AstronauTx is a biotechnology company focused on developing treatments for Alzheimer's disease and other neurodegenerative conditions. The company aims to restore the normal functioning of astrocytes, which are crucial cells in the brain that support neuronal activity, metabolism, and the integrity of the blood-brain barrier. In conditions such as dementia, astrocytes can become dysfunctional, leading to neurotoxicity and exacerbating disease progression. By targeting astrocyte homeostasis, AstronauTx seeks to enable healthcare professionals to effectively address the underlying mechanisms of neurotoxicity associated with these diseases, ultimately improving treatment options for patients suffering from dementia and related disorders.

VetPartners empowers their people to perform through education, guidance, support, simple processes and respectful relationships. They foster and create connection across their own network and the wider industry they work in. They are committed to doing what is right, being empathetic and supportive.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

To continue to develop our position as an international, high margin, cash generative, specialist Veterinary Pharmaceuticals and related products business with clear focus on key therapeutic areas.

VarmX is a pharmaceutical spin-off from the Leiden University Medical Center focused on developing and manufacturing therapeutic proteins aimed at restoring blood clotting in patients experiencing severe bleeding. The company's lead product, PseudoXa, is a modified recombinant human coagulation factor X designed to work effectively in the presence of direct factor Xa anticoagulants like rivaroxaban, apixaban, and edoxaban. These anticoagulants are widely used for preventing and treating thrombosis and stroke but can lead to dangerous bleeding as a side effect. PseudoXa addresses this critical issue by providing a means to stop and prevent bleeding, thereby enhancing the safety of anticoagulant therapies for millions of patients worldwide.

Evommune, Inc. is a biotechnology company based in Los Altos, California, that focuses on developing and manufacturing tissue-based medicines aimed at treating inflammatory diseases. Founded in 2020, the company employs a proprietary tissue-based platform to accelerate the discovery of novel therapies, with a particular emphasis on immunology and dermatology. Evommune's approach seeks not only to alleviate the symptoms of inflammatory disorders but also to halt disease progression, thereby improving the quality of life for patients. Its pipeline includes initiatives targeting prevalent inflammatory conditions, with a commitment to advancing patient care by creating best-in-class treatment options. Through innovative strategies, Evommune aims to drive meaningful advancements in the field of inflammatory disease management.

Noya is focused on addressing climate change by retrofitting existing industrial equipment to capture carbon dioxide from the atmosphere. The company's innovative technology utilizes a non-toxic chemical blend that is added to the cooling towers of various industries without requiring any structural modifications. This approach allows for effective CO2 capture while enabling businesses to contribute to environmental sustainability. By selling the captured carbon dioxide to companies that utilize it as a raw material, Noya facilitates a practical and scalable solution for reducing carbon emissions and promoting a transition towards a carbon-negative future.

Lazer Logistics specializes in providing outsourced yard management services to a diverse range of industries, including food and beverage, consumer packaged goods, e-commerce retail, and pulp and paper. The company offers comprehensive solutions that include yard spotting, trailer shuttling, rental services, and staffing for gate personnel. By managing the movement of loaded and empty trailers within customer yards and offsite locations, Lazer Logistics ensures efficient operations at production and distribution sites. Additionally, they implement computerized yard management systems and provide training to enhance safety and streamline processes for their clients.

GotPhoto offers a software-as-a-service platform designed for photographers specializing in school and volume photography. The company provides a comprehensive system that streamlines the online sales process for photographers, enabling them to efficiently manage their workflow and e-commerce needs. By simplifying the process of selling photos, GotPhoto positions itself as a key resource for photographers looking to enhance their business operations and increase revenue.

Tion Renewables operates a European portfolio of wind and solar farms with an installed capacity.

IntegrityNext is a company based in Munich, Bayern, focused on providing a cloud-based platform for monitoring supplier sustainability and compliance. Established in April 2016 by Martin Berr-Sorokin, the platform allows businesses to automatically gather necessary supplier self-assessments and certifications while also monitoring social media for potential malpractice and reputational risks. Through its features, which include automated self-assessments, risk alerts, and a pre-built supplier questionnaire, IntegrityNext helps small and medium-sized enterprises navigate compliance data requirements set by international regulators. The platform's real-time dashboard and assessment framework enable companies to effectively manage compliance risks and streamline their processes.

QurAlis Corporation is a clinical-stage biotechnology company focused on discovering and developing therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Based in Cambridge, Massachusetts, the company utilizes proprietary platforms and biomarkers to create precision medicines targeting genetically validated disease-causing alterations. Its pipeline includes various treatments aimed at specific subtypes of ALS, such as therapies designed to restore dysfunctional cellular waste clearance, manage overactive neurons to prevent cell death, and eliminate toxic proteins. QurAlis aims to advance its antisense oligonucleotides and small molecule programs to address the most prevalent forms of ALS, ultimately working to halt disease progression and improve patient outcomes. The company was incorporated in 2016 and operates as a subsidiary of Q-State Biosciences, Inc.

SK Shielders provides cyber security, physical security, convergence security, and safety care services. They also offer caps home door guard, caps home inner guard, caps unmanned guard, mobile guard, infosec cloud guard, caps cyber guard, caps smart walk-in, caps smart check, caps view guard AI, and caps mobile access card.

Radius Global Infrastructure is one of the largest international aggregators of rental streams underlying wireless communications.

Xeltis is a clinical-stage medical device company focused on transforming cardiovascular treatment through innovative restorative technologies. The company has developed advanced polymer-based devices, including bioabsorbable heart valves and implantable small diameter blood vessels, intended for hemodialysis vascular access and coronary artery bypass graft surgery. These devices leverage proprietary technology to facilitate endogenous tissue restoration, allowing the body to naturally regenerate the complex structures being replaced. Xeltis emerged from the merger of two university spin-offs from the Netherlands and Switzerland and operates in both the Netherlands and the USA. The company is backed by several venture capital firms and has secured significant funding from the European Investment Bank and the European Innovation Council Accelerator. Currently, Xeltis is conducting ongoing clinical trials to advance its restorative cardiovascular solutions.

Cardiac Dimensions, Inc. is a medical device company focused on developing minimally invasive treatments for heart failure and associated cardiovascular conditions. The company is known for its Carillon Mitral Contour System, a permanent implant designed to treat functional mitral regurgitation through a non-surgical, catheter-based approach that reshapes the mitral valve and reduces regurgitation. Established in 2000, Cardiac Dimensions is headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany.

Founded in 1933, the Saur Group is the third largest player in the French water distribution and waste water management market. In addition to its core activity, the company has also developed into municipal waste collection and treatment, and also certain ancillary services to local authorities.

Ontinue offers AI-powered Managed Extended Detection and Response (MXDR) services through its advanced security operations platform. This platform focuses on enhancing detection and response capabilities by leveraging artificial intelligence to improve communication and streamline processes. By providing innovative prevention services, Ontinue enables its clients to optimize operational efficiency and elevate the maturity of their security programs. The company's solutions are designed to meet the evolving security needs of organizations, ensuring robust protection against emerging threats.

Cirba Solutions is a circular supply chain for battery materials is created using a circular economy model, which recycles old resources and reintroduces them into the value chain for reuse with low waste. Cirba Solutions collects end-of-life batteries, processes them to extract critical materials, and reintroduces these materials into the supply chain. Cirba Solutions' battery recycling management platform provides battery-centric logistics, collection program solutions, second-life applications, and validate cathode production, all while emphasizing environmental compliance through technological processes.

SHL Medical AG is a Swiss company based in Zug that specializes in designing, developing, and manufacturing advanced drug delivery systems, including auto-injectors, pen injectors, and inhaler systems. Founded in 1989, the company serves pharmaceutical and biotechnology companies worldwide by providing comprehensive services that include final assembly, labeling, and packaging. In addition to its core focus on drug delivery systems, SHL Medical also offers contract manufacturing services and produces various medical products such as pressure mattress systems and patient lifting slings. The company is committed to maintaining high-quality standards and adhering to strict regulatory requirements, ensuring it delivers innovative solutions tailored to the needs of its clients.

Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.

Billtrust is a provider of cloud-based software and integrated payment processing solutions designed to enhance B2B commerce by automating accounts receivable (AR) processes. Recognizing the inefficiencies of traditional, paper-based methods, Billtrust aims to digitally transform AR through a comprehensive platform that covers the entire order-to-cash cycle. This includes key functions such as credit decisioning, online ordering, invoicing, cash application, and collections. By integrating with various ecosystem participants, including financial institutions and enterprise resource planning systems, Billtrust enables businesses to transition from costly paper invoicing to efficient electronic billing and payments. This transformation accelerates revenue capture, improves cash flow, and enhances the overall user experience for clients.

eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies that harness the key role of dendritic cells in the immune system. The company focuses on treating melanoma, triple-negative breast cancer, and infectious diseases through its innovative TriMix technology, which enhances the immune response. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA collaborates strategically with China Grand Pharmaceutical and Healthcare Holdings Limited to advance its research and development efforts. The company aims to lead in nucleic acid-based medicine, enabling partners to create new therapeutic options and improve patient outcomes.

FundamentalVR have been working with leading pharmaceutical companies to combine virtual and mixed reality with haptic feedback using their ‘FeelRealVR’ platform to create simulated surgical procedures to help educate and train healthcare professionals. The company works at the nexus of haptics, machine learning, and immersive technologies (XR). FundamentalVR was established in 2012 by Chris Scattergood in London, England.

Xilis, Inc. is a biotechnology company based in Chapel Hill, North Carolina, founded in 2019. It specializes in developing advanced organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. The company's flagship platform, XilisµO, facilitates rapid diagnostics and personalized drug screening while providing scalable, patient-derived models for high-throughput drug discovery. This technology supports physicians and pharmaceutical companies in creating tailored treatments by enabling effective drug screening, ultimately contributing to more precise and cost-efficient cancer therapies.

SPT Labtech specializes in designing and manufacturing automated instrumentation and consumables for life science research. Their product portfolio focuses on sample management, liquid handling, and multiplexed detection, which help to minimize assay volumes, enhance workflows, and reduce costs in fields such as drug discovery, structural biology, molecular biology, and genomics. By addressing existing customer challenges, SPT Labtech fosters innovation through its research and development efforts. The company prides itself on its deep application knowledge and engineering expertise, which allows it to support customers throughout the entire product lifecycle, from initial design to final manufacturing and sale. This comprehensive approach not only enhances productivity for life scientists but also strengthens client relationships through reliable technical and mechanical support.

ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.

Ariceum Therapeutics is a clinical-stage radiopharmaceutical company that focuses on the detection and targeted treatment of aggressive cancers, particularly neuroendocrine tumors and other challenging malignancies. The company's lead product, 177Lu-satoreotide tetraxetan (Satoreotide), acts as an antagonist of the somatostatin type 2 receptor (SSTR2), which is commonly overexpressed in many neuroendocrine tumors. Ariceum is developing Satoreotide as a theranostic pair, which allows for both the diagnosis and targeted radionuclide treatment of neuroendocrine malignancies, certain aggressive tumors, and childhood cancers. This approach aims to provide treatment options for conditions that currently have limited therapies and poor prognoses, enabling healthcare professionals to deliver more effective treatments with reduced side effects.

Envirotainer AB specializes in the production, development, and rental of active temperature-controlled containers designed for the air transportation of temperature-sensitive healthcare products. Established in 1986 and headquartered in Upplands Väsby, Sweden, the company operates internationally with facilities in major locations such as Singapore, Dallas, Frankfurt, and Toronto, along with a network station in Hyderabad. Envirotainer serves a diverse clientele, including pharmaceutical and biotech companies, by offering a comprehensive suite of services that encompasses laboratory testing, qualification, validation support, and training through the Qualified Envirotainer Program. With over 30 years of experience, Envirotainer has established itself as a leader in secure cold chain solutions, ensuring that pharmaceutical products are transported in a controlled environment to meet the demands of the global market.

Guardian is the local Chinese pest control operator, with a strong presence in Eastern and Southern China.

Ardoq AS is a software company based in Oslo, Norway, with additional offices in New York, London, and Copenhagen. Established in 2013, Ardoq specializes in enterprise architecture solutions that facilitate the documentation and management of complex computer systems. Its platform combines textual documentation with interactive visualizations, allowing users to generate diagrams and insights in real-time. Ardoq's features include business capability mapping, risk and security architecture, and data flow integration, all designed to support organizations in their digital transformation efforts. The software enhances collaboration among developers, project managers, architects, and stakeholders by providing dynamic overviews and dashboards that highlight the interdependencies between technology and organizational processes.